Patients with heart failure with reduced ejection fraction (HFrEF) did not have better health outcomes if they took sacubitril/valsartan combination therapy compared with valsartan alone, according […]
A program designed to improve hospital care for patients with heart failure, the leading cause of hospitalization among adults over age 65, did not bring additional […]
Patients with heart failure with preserved ejection fractionwho took the antifibrotic drug pirfenidone saw a significant reduction in a marker of heart muscles carring compared with […]
In an important step toward the clinical application of synthetic biology, Rice University researchers have engineered a bacterium with the necessary capabilities for diagnosing a human […]